A similar independent relationship between ESR or CRP and COMP levels was previously described regarding patients with RA treated with adalimumab [38,70], etanercept, or infliximab [68], which may indicate that the cartilage destruction process is not directly linked to inflammation in RA. The gene discussed is CRP; the disease is rheumatoid arthritis.